chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 30 minutes of administered, patient experienced chest pressure; nausea; and headache. Patient was laid on the floor with legs up for 30 minutes. After those 30 minutes, patient  began feeling better without chest pressure, nausea and less headache.  She went home accompanied by her fiance with our reccomendations to laid with legs in an upright position and to go to an emergency room if symptoms persist.
Around 5pm sore arm hard to lift very painful, headache dizzy and nausea. Later on feeling fever and chills. I took 800 mg of ibuprofen it helped through night fever and chills night sweats. In the morning Saturday March 13 on going fever 100.3 degree F soreness and headache continues.
I no longer have symptoms; I had positive reading; This spontaneous case was reported by a consumer and describes the occurrence of CORONAVIRUS TEST POSITIVE (I had positive reading) and ASYMPTOMATIC COVID-19 (I no longer have symptoms) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0274214) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced CORONAVIRUS TEST POSITIVE (I had positive reading). On 01-Apr-2021, the patient experienced ASYMPTOMATIC COVID-19 (I no longer have symptoms). At the time of the report, CORONAVIRUS TEST POSITIVE (I had positive reading) and ASYMPTOMATIC COVID-19 (I no longer have symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       doctor recommended to restart vaccination after 3 months No treatment details were provided.
Pain at injection site, fatigue the day after vaccination, then pain in joints, that started in the left hand, and then spread to other joints, which has continued and grown worse since vaccination almost 1 week ago. My sleep has also been affected, not sleeping soundly.
4" x 7" area with redness, increased skin temp and tenderness (raised) on right shoulder for 3 days.  Subjective fever.  Pruritis. Treatment:  cold compress, Advil or Tylenol and Atarax 25 mg P.O.  QID P/N.
Pt reported accidentally sprayed Hep B vax on face & eyes on 23JUL91 & exp mild irritation for about 1/2 hr & then recovered;
Crying a lot since her immunizations on 10/12/04, 10/16/04 arching back and grabbing at head.
Nurse inadvertently administered 3rd dose of vaccine series without verifying pregnancy status. Pt informed vaccine would be reported to VAERS. Pt states she was not worried.
Rash occurred 1 day after vaccines were administered on both arms. Urticaria present. Pt took OTC Benadryl.
PT EXPERIENCED SORENESS, REDNESS, SWELLING AND ERYTHEMA AROUND THE INJECTION SITE AND SOME RASH AROUND HER ELBOW AT THE BEGINNING. PT TOOK BENADRYL AND SOME OTC FOR PAIN WHICH WAS HELPFUL AND GOT BETTER. SHE CAME 3 DAYS LATER WHEN HER ARM WAS BETTER. SHE WAS EXPERIENCING ITCHING AND SOME SORENESS.
Case number PHEH2013U S022427 is an initial spontaneous report from nurse received on 23 Oct 2013 with a follow up received from nurse on 06 Dec 2013. This case refers to a female patient of an unknown age. The pregnant patient received a shot of FLUVIRIN (batch number: not reported) on 10 Oct 2013. No adverse event was reported following this vaccine exposure during pregnancy. Follow up received from nurse on 06 Dec 2013. It was confirmed that patient didn't receive second FLUVIRIN injection as initially reported.
Around an hour and a half of the J&J vaccine being administered I started to experience itching, large patches of urticaria and swelling on my lips and eye lids even though in the morning I had taken my regular medications which are dapsone and antihistamines where administered IV prior to getting vaccinated, that evening my GP prescribed 40mg of prednisolone, however symptoms kept progressing. The angioedema and urticaria kept getting worse and progressing over the next few days until on the 26th of October my neck, tongue, face and eyelids started to swell uncontrollably until I started having difficulty breathing, oxygen saturation was getting low ( around 85) , I was coughing and wheezing and had to self inject using an Epipen.
Stool was loose and green x 1 week 1-2 days after Rota was given.
High fever (over 104 degrees) that was difficult to "get down".  Patient appreared lethargic.
Started having Heart Palpitations the evening after the vaccine. Also started to get fatigued at that time. Fatigue was gone by Sunday morning(two days after shot) but I have been having the Heart Palpitations on and off since the 17th.  They don?t really hurt but I do feel like when they are strong, my chest feels heavy. I have not been to a doctor because the consistency changes. I will wait another week and see if the symptoms get better and go away.
The patient presented to the pharmacy for her booster dose of the Pfizer Covid-19 vaccine and her high dose influenza vaccine. The first vaccine give was the Pfizer Covid vaccine in her left arm. She was supposed to receive the high dose influenza vaccine in her right arm but was accidently given a second dose of the Pfizer Covid vaccine. She did not receive the flu vaccine that day since she had accidently received a double Pfizer Covid vaccine dose. Patient was told of the mistake and advised to look out for any significant side effects such as fever, aches, headache, and sore arms. The plan is to call patient on 9/30/21 to see how she is doing. She waited in pharmacy for 20 minutes with no apparent side effects.
1. Very very mild headache, before bed, 1/13.  Approx. 1:30 am, Awful terrible all-over body aches began - and grew more severe ( and I have fibromyalgia/ I deal with all-over pain every day - this was far, far worse) and continued for hours, throughout Friday.  Friday morning, I became totally incontinent.  Totally, out of the blue. OTC pads & garments were my salvation. This lasted for 3-4 days, before my control Slowly began to recover. It did.  During the Evening (6-7 pm? ) 1/14/22,  I found I could not move my legs At All. I tried to move them with my arm and hands, because they were slightly tangled.  I could not - I don?t know if it was because I was weak, being I?ll, or the legs were just too heavy. They were paralyzed.  I COULD NOT SIGNAL FOR HELP - I could not move to bang on a wall, to get my husband?s attention - he was downstairs watching TV.  I could not call out loud enough to be heard down below.  I could not reach my phone either.  It was TERRIFYING.   All I could do was tell him when he came to bed, many hours later.  The paralysis continued overnight, and into the morning , noon of 1/15/22, and gradually I recovered movement  that day. The pain faded too, by Sunday, 1/16/22, I was totally wiped out, and still incontinent, but recovering .  That is, to the best of my memory my pretty awful experience.  I do want my 2nd Covid booster - but I Am fearful of this happening again.  If IF it does, I?m going to be evaluated at the ER, for possible short-term hospital care.
Systemic: Dizziness / Lightheadness-Mild, Systemic: LOW BLOOD PRESSURE-Mild, Systemic: Hypotension-Medium, Additional Details: Her Blood pressure was 87/90 when she complained about dizziness.
Pt passed soon after; shortly after progressed with other covid symptoms and was admitted / acute resp failure, COVID pneumonia; acute resp failure, COVID pneumonia; Became hypotensive due to massive hamatoma 2' bleeding into abd rectus muscle.; Became hypotensive due to massive hamatoma 2' bleeding into abd rectus muscle.; Became hypotensive due to massive hamatoma 2' bleeding into abd rectus muscle.; This is a spontaneous report from a non-contactable Pharmacist.  A 76-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE lot number EL3247), intramuscular on 19Jan2021 at single dose for COVID-19 immunisation. The patient medical history included COVID symptoms from 16Jan2021 and ongoing. Concomitant medications were not reported. The patient with acute resp failure, COVID pneumonia, that developed symptoms 9 days prior to admit and ultimately received first vaccine 6 days prior to a admit, then shortly after progressed with other covid symptoms and was admitted on 25Jan2021. She decompensated while intp and was transferred to ICU for rising O2 needs, ultimately had to be intubated. Became hypotensive due to massive hamatoma 2' bleeding into abd rectus muscle. Sx and IR consulted and did beside exploration of hematoma. Initially blood pressure responded but overnight continued with refractory hypotension. Maxed out vasopressin and levophed, hemodynamics deteriorated. The patient died on 02Feb2021. It was not reported if an autopsy was performed.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events death, COVID-19 pneumonia, acute respiratory failure, hypotension, abdominal wall haematoma and abdominal wall haemorrhage cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Pt passed soon after
Joint aches - starting 3/21/2021, lasting 24 hours Swollen lymph gland in left armpit - starting 3/22/2021, lasting 36 hours Acute swelling of pre-existing small sebaceous cyst on left breast, becoming 5 times the size it had been for 12 years prior, with additional larger swelling behind it - started swelling 3/23/2021; extreme tenderness and redness developed with continued swelling, then infection, over the next two weeks, despite taking prescribed 10-day course of antibiotic (Cephalexin 500 mg) -- ultimately required surgical lansing, irrigation, and draining and follow-up with breast surgery center 4/7/2021 (cont.)
Severe lower body pain below the waist beginning the day after the 1st vaccination.  This continued to intensify that limited mobility.  Received the 2nd vaccine on 2/11/2021 and the symptoms intensified to the point of not being able to walk.  Since the first vaccine I have tried numerous things to alleviate the pain and increase mobility including:  visiting my general doctor, being prescribed steroids, visiting orthopedic, visiting chiropractor, having acupuncture, and other homeopathic remedies.  Today I am visiting the emergency room due to the pain and mobility issues.  I am still having severe pain and limited mobility.
Pfizer Covid-19 vaccine administered on  04/08/2022 date has been determined to be outside of the recommended stability guidelines by Pfizer and the CDC and a repeat dose is recommended.
Patient reported nausea/ fever. She was treated in the emergency room. She also reports having a headache 1 week after administration.
Injection site swollen, firm, red, hot, very painful arm, feels heavy painful down to elbow. Day after injection chills, aches, feeling warm, flushed.
First 24 hours: Sore arm, swelling, tenderness to touch, redness around injection site, fatigue, stomach upset, headache, sore neck on left side. After 36 hours: Warmth and swelling around injection site which spread further below the injection site. Increased swelling, tenderness to touch, less soreness in arm, continuing fatigue. After 48 hours: Warmth, swelling somewhat reduced, redness spread further down from injection site, itching, still tender to touch.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No medical history, concomitant medication and current conditions were reported. The reporter stated that the patient received the first dose of GARDASIL on 28-AUG-2012, and the second dose on 06-NOV-2012 (Dose, Lot number and expiration date were not reported both doses). It was reported that the patient was on the office to receive the third dose of GARDASIL on 19-AUG-2014. No adverse event was reported. Additional information has been requested.
Fever started at 1:30 AM on March 26, headache and tiredness, body aches. Also red, hot area at injection site on left arm continues to March 27, 2021.
No additional AE reported; Patient was administered expired PNEUMOVAX 23 via corresponding PNEUMOVAX 23 Prefilled Syringe on 09/13/2022.; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On 13-SEP-2022, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # T039322, has been verified to be a valid lot number for pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), expiration date reported and upon internal validation established as 09-SEP-2022) (dose, anatomical location and route of administration were not reported) for prophylaxis (Expired product administered).  No adverse event was reported. No temperature excursion was reported.
headache within 15 minutes of administration, 16 hours following administration fever and chills began, 22 hours after administration a recorded temperature of 100.7 was noted,  27 hours after administration a fever of 101.1 was noted upon which 200mg ibuprofen was  taken along with rest and fluids, 49 hours after administration a 99.4 degree fever was noted and 200mg ibuprofen was taken, 72  hours after administration a 99.8 degree fever was noted and 200mg ibuprofen was taken with an additional dose of 200mg ibuprofen taken at 77 hours after administration due to feeling fever-ish.
pt recv vax 20AUG97 & 5SEP97 pt devel a few vesicles that look suspicious about 7 vesicles on face, arm, & trunk;
Three weeks later after symptoms occurred. Patient called complaining of muscle and joint pain and stiffness. Yesterday on 10-22-09 patient was running a fever of 100.1. That is the only temperature that patient has recorded as being high. Patient is coming in today to go over symptoms and recent laidwork with Dr.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a first 0.5 ml dose of GARDASIL by intramuscular injection (lot number and injection site not reported). Concomitant therapy included MENACTRA and an unspecified vaccine. Immediately after injection, the patient experienced dizziness. The patient went to see the doctor. Subsequently the patient recovered from the event. The physician also reported that on an unspecified date the patient was vaccinated with a second dose of GARDASIL (lot number, injection site and route not reported). The patient felt fine after the vaccination. Additional information has been requested.
Information has been received from a health professional concerning a 14 year old white female (115.4 pounds, 63 inches) with seasonal allergies who on 16-Aug-2007 was vaccinated IM with Gardasil (lot #658490/0802U).  On 05-Sep-2007 the patient visited the physician's office with a fever, sore back, headache, vomiting and joint discomfort.  ANA, ASO, urine "C and S" were negative (not further specified).  The patient had her second IM injection, in the left arm, of Gardasil (lot #659435/1265U) on 24-Oct-2007 and on 28-Oct-2007 began to experience the same symptoms except without vomiting.  Subsequently she recovered.  Additional information is not expected.
Patient given MMRV. Within 15 minutes, developed hives and itchy throat. Liquid Benadryl PO was given. Within 5 minutes after that, developed wheezing and Epinephrine pen administered, given oxygen via mask. Ambulance called and he was transported to the hospital for monitoring.
Patient was in store to receive the second Moderna vaccination and the pharmacist gave the J&J vaccine instead. No adverse events happened while patient was in the store
pt recv vax 20SEP95 & exp gen erythema & hives;tx w/epi & DPH;hives appeared to resolve;1wk later devel a fever;pt recovered from hives;
During obs, member became pale, felt faint, appeared to be hyperventilating and was obviously very anxious. Adult emergency called. Moved to holding room. BP 80s/40s O2 sats 60%, patient hyperventilating, c/o numbness in her hands and fingers. Alert and oriented, talking the whole time and very anxious. Member improved with O2 sats 100% BP 120/56. Observed x1 hr.
Severe tinnitus in right ear.  I have had tinnitus for 34 years off/on.  After the shot (approximately 3-4 days later) my right ear began a screaming hiss.  Some 29 days later it is still screaming.  My left ear is fine but the R. ear severely impacted by the shot.
3-4 days after the first vaccine, pt noticed "shockwave" going down right leg.  After nap, when he got up, his legs gave out underneath him.  As the day progressed, he fell several times.  Has hx of problems with balance and would use cane most of the time but since vaccination, has had to use walker and wheelchair.  Pt has pins and needles feeling in hands and feet, numbness, can't grasp papers in hands.  Also states has been feeling depressed since vaccination, crying "out of the blue"
Information has been received from a 69 year old female with lupus and allergic to sulfa who on 12-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine.  The patient reported that she received a flu vaccine at the same time that she received the pneumococcal 23v polysaccharide vaccine.  On 12-OCT-2005 the patient reported that she felt " dizzy, weak, and generally debilitated" after receiving pneumococcal 23v polysaccharide vaccine.  The patient did not seek medical attention.  Laboratory diagnostic studies were reportedly not performed.  At the time of the report the patient was recovering from feeling dizzy, weak, and generally debilitated.  Additional information is not expected.
Symptoms:  Paleness, Nausea, Sweating, Lightheadedness, low blood pressure; orientation x3.  Vitals: 10:25am - b/p 98/60, p 72, r 16 10:35am- b/p 108/70, p 72, r 18; 10: 40AM - B/P 108/72, P 64, R 18, NO PULSE OX available.  Patient was noted to be hanging his head and pale 5 min after receiving the vaccine.  Pt states this "happens all the time" when receiving immunizations and was expected.  Father has similar reaction with blood draws and vaccines.  Patient was placed on floor in supine position with feet elevated on chair.  BP improved, color returned to face.  Stated feeling dizzy, diaphoretic and nauseous.  Pt given water to sip.  Declined foot, had not eaten yet today.  VSS, alert and oriented throughout eventually up in chair and then standing with no complaints.  Discharged ambulatory from monitoring area accompanied by father.  Encouraged to drink fluids liberally and avoid strenuous exercise/activity today.  Disposition:  Alert , color returned, subjectively states feeling fine, ambulated with steady gait.  Discharged with dad.
Sinus infection; Spontaneous report received on 23DEC2019.  A pharmacist reported that a female consumer developed "sinus infection" (PT: Sinusitis), after completing the course of oral Vivotif for typhoid fever prophylaxis. On 19DEC2019, she had completed the course of Vivotif and then developed sinus infection. The pharmacist stated that she might developed the sinus infection on 22DEC2019 as she visited the doctor on that day and was prescribed with Zithromax (azithromycin) for sinus infection, which she had not started yet. It was reported that the pharmacist did not know if she had a history of sinus infection. Action taken with Vivotif with respect to the reported event was not applicable. She was not recovered from the reported event at the time of report.  The reporter considered the event of "sinus infection" was unrelated to Vivotif.  Company Comment: A consumer developed sinus infection after three days of completion of Vivotif course and then she was prescribed with Zithromax which she has not started taking yet. Considering the infectious nature of sinus infection, the causality of the event is assessed as not related to Vivotif.; Sender's Comments: A consumer developed sinus infection after three days of completion of Vivotif course and then she was prescribed with Zithromax which she has not started taking yet. Considering the infectious nature of sinus infection, the causality of the event is assessed as not related to Vivotif.
3 days after the vaccine, the patient started experiencing blistering itchy skin lesions all over the body that lasted for a week and resolved with sloughing of skin and leaving hyperpigmented spots.  The patient took Benadryl and Zyrtec without any improvement.
Headaches and body aches since the day of 4/14/17, started with fever, neck pain and confusion 04/17/2017.
Pt had episode upper airway obstruction and cyanosis 2nd day after immunizations. Extensive work up revealed severe GERD and pt placed on monitor and Prevacid and did well.
Dose administered after 30-day Use By Date or after manufacturer date of expiry; No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (batch no. 011B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Sep-2022, the patient received first dose of mRNA-1273  (unknown route) 1 dosage form. On 26-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date or after manufacturer date of expiry).    No concomitant medication was reported.   Printed expiration date: 25-Sep-2022     Vial did not undergo any temperature excursions.   No treatment medication was reported.
Moderate to severe itching and swelling of upper left arm. Firm and hot to the touch, tennis ball size rash appeared at injection site suddenly over a week after the first injection. Additionally, for 4-5 days following the vaccination: minor itching and swelling of injection site. Low grade fever (99.7 to 100.8), chills, extreme fatigue, weakness and mild nausea. Unable to perform many work tasks/chores. These symptoms all subsided prior to the onset of the severe arm rash and swelling.